Which of the following is given to treat thrombocytopenia secondary' to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?: (A) Filgrastim, (B) Oprelvekin, (C) Erythropoietin, (D) Anagrelide
Answer is B. Ans. is 'b' i.e., Oprelvekin o Oprelvekin (1L-11) is used to prevent and treat thrombocytopenia.